Erratum: Interleukin-4-mediated 15-lipoxygenase-1 trans-activation requires UTX recruitment and H3K27me3 demethylation at the promoter in A549 cells (PLoS ONE (2014) 9:1 (e85085) DOI:10.1371/journal.pone.0085085);Interleukin-4-mediated 15-lipoxygenase-1 trans-activation requires UTX recruitment and H3K27me3 demethylation at the promoter in A549 cells

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Han, Hongya ^a   Xu, Dawei ^a   Liu, Cheng ^b   Claesson, Hans Erik ^a   Björkholm, Magnus ^a   Sjöberg, Jan ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE 1; HISTONE H3; INTERLEUKIN 4; OXYGENASE; PROTEIN UTX; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; ALOX15 PROTEIN, HUMAN; ARACHIDONATE 15 LIPOXYGENASE; HISTONE; HISTONE DEMETHYLASE; NUCLEAR PROTEIN; PROTEIN BINDING; UTX PROTEIN, HUMAN;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DEMETHYLATION; EMBRYO; ENZYME ACTIVITY; GENE SILENCING; HISTONE MODIFICATION; HODGKIN DISEASE; HUMAN; HUMAN CELL; LUNG CARCINOMA; MONOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSCRIPTION INITIATION; CELL CULTURE; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DRUG EFFECTS; GENETICS; METABOLISM; TUMOR CELL LINE;

ARACHIDONATE 15-LIPOXYGENASE; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; HISTONE DEMETHYLASES; HISTONES; HUMANS; INTERLEUKIN-4; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING;

EID: 84896295497     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091499     Document Type: Erratum

References (43)

1. Claesson HE (2009) On the biosynthesis and biological role of eoxins and 15-lipoxygenase-1 in airway inflammation and Hodgkin lymphoma. Prostaglandins Other Lipid Mediat 89: 120-125.
2. Nassar GM, Morrow JD, Roberts LJ 2nd, Lakkis FG, Badr KF (1994) Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. Jô Biol Chem 269: 27631-27634. (Pubitemid 24346597)
3. Bhattacharjee A, Mulya A, Pal S, Roy B, Feldman GM, et al. (2010) Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity. Jô Immunol 185: 5211-5224.
4. Brinckmann R, Topp MS, Zalan I, Heydeck D, Ludwig P, et al. (1996) Regulation of 15-lipoxygenase expression in lung epithelial cells by interleukin-4. Biochemô Jô 318 (Pt 1): 305-312. (Pubitemid 26283660)
5. Schewe T (2002) 15-lipoxygenase-1: a prooxidant enzyme. Biol Chem 383: 365-374.
6. Kuhn H, O'Donnell VB (2006) Inflammation and immune regulation by 12/15-lipoxygenases. Prog Lipid Res 45: 334-356.
7. Chu HW, Balzar S, Westcott JY, Trudeau JB, Sun Y, et al. (2002) Expression and activation of 15-lipoxygenase pathway in severe asthma: relationship to eosinophilic phenotype and collagen deposition. Clin Exp Allergy 32: 1558-1565. (Pubitemid 35370530)
8. Zhao J, Maskrey B, Balzar S, Chibana K, Mustovich A, et al. (2009) Interleukin-13-induced MUC5AC is regulated by 15-lipoxygenase 1 pathway in human bronchial epithelial cells. Amô Jô Respir Crit Care Med 179: 782-790.
9. Kuperman DA, Lewis CC, Woodruff PG, Rodriguez MW, Yang YH, et al. (2005) Dissecting asthma using focused transgenic modeling and functional genomics. Jô Allergy Clin Immunol 116: 305-311. (Pubitemid 41096536)
10. Hennig R, Kehl T, Noor S, Ding XZ, Rao SM, et al. (2007) 15-lipoxygenase-1 production is lost in pancreatic cancer and overexpression of the gene inhibits tumor cell growth. Neoplasia 9: 917-926. (Pubitemid 350086437)
11. Heslin MJ, Hawkins A, Boedefeld W, Arnoletti JP, Frolov A, et al. (2005) Tumor-associated down-regulation of 15-lipoxygenase-1 is reversed by celecoxib in colorectal cancer. Ann Surg 241: 941-946; discussion 946-947.
12. Nixon JB, Kim KS, Lamb PW, Bottone FG, Eling TE (2004) 15-Lipoxygenase-1 has anti-tumorigenic effects in colorectal cancer. Prostaglandins Leukot Essent Fatty Acids 70: 7-15. (Pubitemid 38021636)
13. Shureiqi I, Wojno KJ, Poore JA, Reddy RG, Moussalli MJ, et al. (1999) Decreased 13-S-hydroxyoctadecadienoic acid levels and 15-lipoxygenase-1 expression in human colon cancers. Carcinogenesis 20: 1985-1995. (Pubitemid 29476127)
14. Shureiqi I, Xu X, Chen D, Lotan R, Morris JS, et al. (2001) Nonsteroidal anti-inflammatory drugs induce apoptosis in esophageal cancer cells by restoring 15-lipoxygenase-1 expression. Cancer Res 61: 4879-4884. (Pubitemid 32691905)
15. Claesson HE, Griffiths WJ, Brunnstrom A, Schain F, Andersson E, et al. (2008) Hodgkin Reed-Sternberg cells express 15-lipoxygenase-1 and are putative producers of eoxins in vivo: novel insight into the inflammatory features of classical Hodgkin lymphoma. FEBSô J 275: 4222-4234.
16. Kelavkar UP, Nixon JB, Cohen C, Dillehay D, Eling TE, et al. (2001) Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 22: 1765-1773. (Pubitemid 33064840)
17. Roy B, Cathcart MK (1998) Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. Jô Biol Chem 273: 32023-32029. (Pubitemid 29177143)
18. Kelavkar U, Wang S, Montero A, Murtagh J, Shah K, et al. (1998) Human 15-lipoxygenase gene promoter: analysis and identification of DNA binding sites for IL-13-induced regulatory factors in monocytes. Mol Biol Rep 25: 173-182. (Pubitemid 28324691)
19. Liu C, Schain F, Han H, Xu D, Andersson-Sand H, et al. (2012) Epigenetic and transcriptional control of the 15-lipoxygenase-1 gene in a Hodgkin lymphoma cell line. Exp Cell Res 318: 169-176.
20. Zuo X, Morris JS, Shureiqi I (2008) Chromatin modification requirements for 15-lipoxygenase-1 transcriptional reactivation in colon cancer cells. Jô Biol Chem 283: 31341-31347.
21. Liu C, Xu D, Han H, Fan Y, Schain F, et al. (2012) Transcriptional regulation of 15-lipoxygenase expression by histone h3 lysine 4 methylation/demethylation. PLoS One 7: e52703.
22. Shi L, Wu J (2009) Epigenetic regulation in mammalian preimplantation embryo development. Reprod Biol Endocrinol 7: 59.
23. Cao R, Wang L, Wang H, Xia L, Erdjument-Bromage H, et al. (2002) Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 298: 1039-1043. (Pubitemid 35247314)
24. Fang TC, Schaefer U, Mecklenbrauker I, Stienen A, Dewell S, et al. (2012) Histone H3 lysine 9 di-methylation as an epigenetic signature of the interferon response. Jô Exp Med 209: 661-669.
25. Kondo Y, Shen L, Issa JP (2003) Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. Mol Cell Biol 23: 206-215. (Pubitemid 36008514)
26. Varier RA, Timmers HT (2011) Histone lysine methylation and demethylation pathways in cancer. Biochim Biophys Acta 1815: 75-89.
27. Ishii M, Wen H, Corsa CA, Liu T, Coelho AL, et al. (2009) Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 114: 3244-3254.
28. Cloos PA, Christensen J, Agger K, Helin K (2008) Erasing the methyl mark: histone demethylases at the center of cellular differentiation and disease. Genes Dev 22: 1115-1140. (Pubitemid 351656572)
29. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, et al. (2007) UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 449: 731-734. (Pubitemid 47552088)
30. Lee MG, Villa R, Trojer P, Norman J, Yan KP, et al. (2007) Demethylation of H3K27 regulates polycomb recruitment and H2A ubiquitination. Science 318: 447-450. (Pubitemid 47614529)
31. Liu C, Xu D, Sjoberg J, Forsell P, Bjorkholm M, et al. (2004) Transcriptional regulation of 15-lipoxygenase expression by promoter methylation. Exp Cell Res 297: 61-67. (Pubitemid 38759562)
32. Zhang C, Richon V, Ni X, Talpur R, Duvic M (2005) Selective induction of apoptosis by histone deacetylase inhibitor SAHA in cutaneous T-cell lymphoma cells: relevance to mechanism of therapeutic action. Jô Invest Dermatol 125: 1045-1052.
33. Hsi LC, Xi X, Lotan R, Shureiqi I, Lippman SM (2004) The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Cancer Res 64: 8778-8781. (Pubitemid 39552097)
34. Xu D, Gruber A, Peterson C, Pisa P (1998) Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Brô Jô Haematol 102: 1367-1375. (Pubitemid 28435229)
35. Satoh T, Manel N (2013) Gene transduction in human monocyte-derived dendritic cells using lentiviral vectors. Methods Mol Biol 960: 401-409.
36. Goujon C, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, et al. (2006) With a little help from a friend: increasing HIV transduction of monocyte-derived dendritic cells with virion-like particles of SIV(MAC). Gene Ther 13: 991-994. (Pubitemid 43827341)
37. Berger G, Durand S, Goujon C, Nguyen XN, Cordeil S, et al. (2011) A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Nat Protoc 6: 806-816.
38. Mahmoudi T, Verrijzer CP (2001) Chromatin silencing and activation by Polycomb and trithorax group proteins. Oncogene 20: 3055-3066. (Pubitemid 32553560)
39. Onodera A, Yamashita M, Endo Y, Kuwahara M, Tofukuji S, et al. (2010) STAT6-mediated displacement of polycomb by trithorax complex establishes long-term maintenance of GATA3 expression in T helper type 2 cells. Jô Exp Med 207: 2493-2506.
40. Conrad DJ, Kuhn H, Mulkins M, Highland E, Sigal E (1992) Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc Natl Acad Sciô Uô Sô A 89: 217-221.
41. Shpargel KB, Sengoku T, Yokoyama S, Magnuson T (2012) UTX and UTY demonstrate histone demethylase-independent function in mouse embryonic development. PLoS Genet 8: e1002964.
42. Miller SA, Mohn SE, Weinmann AS (2010) Jmjd3 and UTX play a demethylase-independent role in chromatin remodeling to regulate T-box family member-dependent gene expression. Mol Cell 40: 594-605.
43. Skinnider BF, Kapp U, Mak TW (2002) The role of interleukin 13 in classical Hodgkin lymphoma. Leuk Lymphoma 43: 1203-1210. (Pubitemid 34537964)